
AI Convergence: Small Molecule Discovery Summit 2026
Description
The AI Convergence: Small Molecule Discovery Summit is an essential gathering for industry leaders and innovators at the forefront of AI and medicinal chemistry. This summit emphasizes the transformative potential of AI and machine learning (AI/ML) in accelerating the design and optimization of small molecules aimed at challenging drug targets.
Highlights
22 world-class AI/ML-guided small molecule discovery speakers. 2 days of exclusive content addressing AI/ML methods, applications, tool convergence, and confidence. Unmatched networking and strategic partnering opportunities. Focused industry-led community of top techbio, pharma, and biotech companies. Explore AI/ML applications that elucidate undruggable target protein folding. Leverage AI/ML-enabled virtual screening to tap into unexplored chemical space. Use generative molecular design for molecular glues, covalent inhibitors, and degraders. Optimize ADME-T and address data input and federated learning platform opportunities. Join industry leaders such as Insilico Medicine, PsiThera, OpenADMET, Sanofi, and Novo Nordisk. Discover the convergence of state-of-the-art AI/ML tools with existing approaches to ignite future AI/ML-enabled small molecule discovery.
Event location
Let your network know you`re going
Share this event to start conversations, invite colleagues, and connect before it begins.
Meet the speakers

Alexander Hillisch
Theme:Head, Digital Molecule Discovery & Executive Director

Devany West
Theme:Software Scientist

Hannes Stark
Theme:PhD Student, MIT, Boltz Team

Hariprasad Vankayalapati
Theme:Chief Scientific Officer, Biolexis Therapeutics

Henry van den Bedem
Theme:Chief Technology Officer
